Business Context and Reporting Period
This Form 6-K filing by GlaxoSmithKline plc covers the period ending July 2009. The report serves as a notification of transactions involving Directors, Persons Discharging Managerial Responsibility, or Connected Persons regarding their interests in the company's Ordinary shares.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This document is strictly a regulatory disclosure of share transactions and does not contain financial performance data.
Material Changes
The material change disclosed is the acquisition of Ordinary shares by eight individuals on July 9, 2009, at a price of £10.96 per share. These acquisitions occurred through the Company's Share Reward Plan ("the Plan").
- Mr A P Witty: Acquired 12 shares (personal contribution) and 12 shares (Company matching contribution).
- Mr J S Heslop: Acquired 12 shares (personal contribution) and 12 shares (Company matching contribution).
- Mr S M Bicknell: Acquired 12 shares (personal contribution) and 12 shares (Company matching contribution).
- Mr E J Gray: Acquired 12 shares (personal contribution) and 12 shares (Company matching contribution).
- Mr S A Hussain: Acquired 12 shares (personal contribution) and 12 shares (Company matching contribution).
- Mr D Learmouth: Acquired 12 shares (personal contribution) and 12 shares (Company matching contribution).
- Mr D S Redfern: Acquired 12 shares (personal contribution) and 12 shares (Company matching contribution).
- Ms C Thomas: Acquired 12 shares (personal contribution) and 12 shares (Company matching contribution).
Guidance, Outlook, and Risks
The filing text does not provide a clear value for guidance, outlook, management commentary, risks, contingencies, or unusual items. The document is limited to the notification of share purchases in accordance with Disclosure and Transparency Rule 3.1.4R(1)(a).
Investor Verification Points
- Verify the share price of £10.96 per Ordinary share on July 9, 2009.
- Confirm the total number of shares acquired by each listed director (24 shares per individual: 12 personal + 12 matched).
- Review the terms of the Company's Share Reward Plan to understand the matching contribution mechanism.
- Note that this filing does not contain financial results; refer to Form 20-F for comprehensive financial data.